Review of Regulations for General Biologics and Licensing and Blood Establishments and Blood Products; Extension of Comment Periods

Краткое содержание

The Food and Drug Administration (FDA) is extending to November 15, 1994, the comment periods for two documents. The documents requested comments on FDA's intent to review certain biologics regulations, and were published in the Federal Register of June 3, 1994 (59 FR 28821 and 28822, respectively). FDA is taking this action in response to requests to allow additional time for public comment.